Cell Pathways Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $79M

Cell Pathways General Information

Description

Developer of products for the treatment and prevention of precancerous lesions and cancer of colon and lung. The company aims in cancer treatment and prevention and to build a pharmaceutical company focused on the oncology market.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 702 Electronic Drive
  • Horsham, PA 19044
  • United States
+1 (215)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 702 Electronic Drive
  • Horsham, PA 19044
  • United States
+1 (215)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cell Pathways Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 12-Jun-2003 $79M Completed Generating Revenue
2. PIPE 09-Nov-2000 Completed Generating Revenue
1. Later Stage VC (Series F) 04-Jun-1997 $17.5M $17.5M Completed Generating Revenue
To view Cell Pathways’s complete valuation and funding history, request access »

Cell Pathways Patents

Cell Pathways Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2002356131-A1 Treatment for cystic fibrosis Inactive 24-Aug-2001
EP-1435782-A1 Treatment for cystic fibrosis Inactive 24-Aug-2001
WO-2003017765-A1 Treatment for cystic fibrosis Inactive 24-Aug-2001
AU-2002356130-A1 Treatment for lupus erythematosus Inactive 23-Aug-2001
EP-1435961-A2 Treatment for lupus erythematosus Inactive 23-Aug-2001 A61K31/165
To view Cell Pathways’s complete patent history, request access »

Cell Pathways Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
BlueGem Capital Partners PE/Buyout Minority
Canaan Partners Venture Capital Minority
Cercano Management PE/Buyout Minority
DMW (Cyprus) Venture Capital Minority
Jackson Capital Management PE/Buyout Minority
You’re viewing 5 of 13 investors. Get the full list »

Cell Pathways FAQs

  • When was Cell Pathways founded?

    Cell Pathways was founded in 1989.

  • Where is Cell Pathways headquartered?

    Cell Pathways is headquartered in Horsham, PA.

  • What industry is Cell Pathways in?

    Cell Pathways’s primary industry is Drug Discovery.

  • Is Cell Pathways a private or public company?

    Cell Pathways is a Private company.

  • What is the current valuation of Cell Pathways?

    The current valuation of Cell Pathways is .

  • What is Cell Pathways’s current revenue?

    The current revenue for Cell Pathways is .

  • How much funding has Cell Pathways raised over time?

    Cell Pathways has raised $41.1M.

  • Who are Cell Pathways’s investors?

    BlueGem Capital Partners, Canaan Partners, Cercano Management, DMW (Cyprus), and Jackson Capital Management are 5 of 13 investors who have invested in Cell Pathways.

  • When was Cell Pathways acquired?

    Cell Pathways was acquired on 12-Jun-2003.

  • Who acquired Cell Pathways?

    Cell Pathways was acquired by OSI Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process